Net Cash Provided by (Used in) Operating Activities |
68.7 M |
USD |
-15.7% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
12.7 M |
USD |
+48.6% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-71 M |
USD |
+45.4% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
431 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
136 M |
shares |
+2.21% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-40.4 M |
USD |
-204% |
Dec 31, 2023 |
2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
21.1 M |
USD |
+87.7% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
4.83 M |
USD |
+111% |
Dec 31, 2023 |
2023 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Gross |
17.7 M |
USD |
+39% |
Dec 31, 2023 |
Q4 2023 |
Deferred Income Tax Expense (Benefit) |
4.82 M |
USD |
-51.6% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
13.7 M |
USD |
+18.9% |
Dec 31, 2023 |
Q4 2023 |
Deferred Federal Income Tax Expense (Benefit) |
22.3 M |
USD |
+95% |
Dec 31, 2023 |
2023 |
Additional Paid in Capital |
654 M |
USD |
+10.3% |
Mar 31, 2024 |
Q1 2024 |
Current State and Local Tax Expense (Benefit) |
209 K |
USD |
|
Dec 31, 2023 |
2023 |
Current Federal Tax Expense (Benefit) |
0 |
USD |
|
Dec 31, 2023 |
2023 |
Deferred Tax Assets, Net of Valuation Allowance |
17.7 M |
USD |
+39% |
Dec 31, 2023 |
Q4 2023 |
Deferred State and Local Income Tax Expense (Benefit) |
1.96 M |
USD |
+39.4% |
Dec 31, 2023 |
2023 |
Interest Expense |
8.14 M |
USD |
+351% |
Mar 31, 2024 |
Q1 2024 |